Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1652 1657 1792
This examiner grants 54% of resolved cases
Rachel E Martin is an examiner in Art Unit 1651 within Tech Center 1700. The examiner has 69 resolved cases. The allowance rate for these cases is 53.6 percent. This 53.6 percent rate shows the frequency of grants within the examiner's total dispositions. The 69 resolved cases provide the data necessary to evaluate the examiner's historical performance. The 53.6 percent rate serves as a baseline for the probability of success in this art unit.
The interview lift is 56.4 percent. This 56.4 percent figure represents the increase in the likelihood of allowance when an interview is held. The 56.4 percent lift is a factor for practitioners to consider when deciding on a prosecution strategy. The median days to allowance is 1180. This 1180 day period measures the time from filing to the grant of a patent. The 1180 day median provides a timeline for the expected duration of the examination process. These metrics from Tech Center 1700 and Art Unit 1651 offer a view of the examiner's procedural tendencies.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18847617 | CARBAMOYL-PHOSPHATE SYNTHETASE LARGE SUBUNIT VARIANT AND L-ORNITHINE PRODUCTION METHOD USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17742035 | PRODUCTION METHOD FOR LIPID PARTICLES IN LIQUID AND METHOD FOR CULTURING MICROORGANISMS | Final Rejection | KANEKA CORPORATION |
| 17570104 | FUSION PROTEIN NANODISK COMPOSITIONS AND METHODS OF TREATMENT | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 17632936 | BACTERIAL STRAIN FOR RELEASING A RECOMBINANT PROTEIN IN A FERMENTATION METHOD | Non-Final OA | Wacker Chemie AG |
| 18277398 | METHOD FOR PRODUCING A HYDROXYTYROSOL | Non-Final OA | Wacker Chemie AG |
| 17618254 | PRODUCTION OF FUCOSYLATED OLIGOSACCHARIDES IN BACILLUS | Final Rejection | Chr. Hansen A/S |
| 17769452 | METHOD FOR EVALUATING DRUG TOXICITY | Non-Final OA | Takeda Pharmaceutical Company Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy